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The diagnostic criteria for low-grade urothelial lesions that have
been described in the past were based on urinary specimens
prepared by the cytospin method. Recognizing the recent popular-
ity of the ThinPrep methodology and the cytologic alterations it
introduces to the cellular features, we sought to evaluate the
reproducibility of these criteria in ThinPrep urinary samples. One
hundred twenty-six ThinPrep urinary specimens with a tissue
diagnosis of low-grade urothelial carcinoma (LGUC) and 45
negative controls were evaluated. Three pathologists blindly re-
viewed the slides separately and the consensus on each feature
was used in the study. Logistic regression analysis was used to
determine which criteria in combination were most predictive of
low-grade urothelial carcinoma. All specimens were evaluated for
the following 18 features: nucleus/cytoplasm ratio, irregular nu-
clear border, cytoplasm homogeneity, cell clusters, high cellular-
ity, prominent nucleoli, granular nuclear chromatin, hyperchro-
masia, acute inflammation, vesicular chromatin, nuclear molding,
nuclear eccentricity, elongated nuclei, necrosis, anisonucleosis,
irregular bordered fragments, absent cytoplasmic collar, and pe-
ripheral palisading. High nucleus-to-cytoplasm ratio, irregular
nuclear borders, and homogeneous cytoplasm (combination sen-
sitivity of 59% and specificity of 100%) were the best predictive
features for LGUC. Minor predictive criteria were eccentric nuclei
and nuclear molding. ThinPrep provides well preserved, cleaner
specimens without significantly altering the morphology. The three
key criteria applied in cytospin specimens to diagnose LGUC were
reproducible in ThinPrep specimens. Diagn. Cytopathol. 2003;
29:125–129. © 2003 Wiley-Liss, Inc.
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Bladder cancers account for 12,600 deaths and more than
56,500 new cases per year, with a male-to-female ratio of
2.7:1.1 More than 90% of the bladder cancers are urothelial
carcinomas. The papillary carcinomas outnumber the flat
ones. The papillary urothelial tumors usually present as low
grade at early stage and involve multiple sites. Although
they often recur, they can be easily managed by local
excision.2,3 According to the 1998 World Health Organiza-
tion and International Society of Urological Pathologists
classification, papillary urothelial neoplasms are classified
as papilloma, urothelial carcinoma with low malignant po-
tential, low-grade urothelial carcinoma, and high-grade
urothelial carcinoma.4
Diagnosing low-grade urothelial carcinoma (LGUC)
on cytologic specimen is very difficult, because the tumor
cells are well differentiated, they may exhibit only a
slight degree of atypia, and they closely resemble normal
urothelial cells. Separating them from reactive, regener-
ative and reparative changes is not always possible. In-
creased nuclear-to-cytoplasmic (N/C) ratio, irregular nu-
clear membrane, and cytoplasmic homogeneity were
three key features reported by Raab et al.5,6 for diagnos-
ing LGUC in cytospin specimens.
ThinPrep preparation (Cytyc, Boxborough, MA) was
initially tested on nongynecologic specimens, as a mono-
layer preparation, and was then introduced as an alterna-
tive to the conventional preparation for cervical smear to
remove obscuring elements and improve the diagnosis.7,8
In recent years, many laboratories have implemented the
ThinPrep method in preparing nongynecologic speci-
mens. The ThinPrep method provides a clear background
with the absence of blood, cell debris, and inflammatory
cells. However, ThinPrep alters the cellular morphology
when compared with conventional preparations. Some of
the reported cytologic alterations of ThinPrep specimens
that may affect the interpretation of LGUC include frag-
mented papillary clusters, more single cells with apparent
discohesion, cells appearing smaller and spindly, en-
hanced nucleoli, increased cytoplasmic density, and less
vesicular chromatin.9,10 In the present study, we under-
took to evaluate those previously described features in
ThinPrep specimens and the most important cytologic
features for diagnosing LGUC.
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Materials and Methods
Cases
The cytology pathology files at the University of Michigan
Medical Center were reviewed retrospectively for the years
1995– 2001. The selected ThinPrep cases included 49 blad-
der washings and 76 void urine specimens with correspond-
ing tissue diagnosis of LGUC within 6 mo. Patient ages
ranged from 41 to 88 yr of age, with a mean of 56 yr. In
addition, 17 bladder washings and 28 voided urine samples
with corresponding tissue diagnosis of inflammation, reac-
tive, or regenerative features within 6 mo were selected as
the control group. Patient ages ranged in age from 40 to 85
yr, with a mean of 54 yr. Table I summarizes the original
cytology diagnoses.
Evaluation
Three pathologists blindly reviewed each case separately
and evaluated the selected previously described eighteen
cytologic features. These features are increased N/C ratio,
irregular nuclear border, cytoplasm homogeneity, cell clus-
ters, high cellularity, prominent nucleoli, granular nuclear
chromatin, hyperchromasia, acute inflammation, vesicular
chromatin, nuclear molding, nuclear eccentricity, elongated
nuclei, necrosis, anisonucleosis, fragments with irregular
border, absent cytoplasmic collar (cytoplasmic rim between
the nucleus and cytoplasmic membrane), and peripheral
palisading.5,6 Samples of the above features are illustrated in
Figure C-1. The consensus on each feature in each case was
consequently reached. For statistical evaluation, we used the
2 test or Fisher’s exact test (if any observed frequency was
5) to obtain P-values.11,12
Results
In biopsy-confirmed LGUC cases, the original diagnosis in
ThinPrep washings, based on the three key criteria (in-
creased N/C ratio, irregular nuclear membrane, and cyto-
plasmic homogeneity), had a sensitivity of 46% and speci-
ficity of 100%. The diagnosis of the ThinPrep voided urine
samples gave a sensitivity of 18.4% and specificity of 100%
(Table II). The washings had a much better sensitivity than
voided specimens, when these criteria were used.
Twelve features were statistically significant (P 
0.01) in frequency between LGUC and benign changes in
both washings and voided urine samples. These twelve
features are increased N/C ratio, cytoplasmic homogene-
ity, irregular nuclear borders, nuclear eccentricity, nu-
clear molding, anisonucleosis, hyperchromatic nuclear
chromatin, elongated nucleus, absent cytoplasmic collar,
granular nuclear chromatin, cell clusters, and necrosis
(Table III). Overall, the rate of incidence of these twelve
features (except for necrosis) was much higher in wash-
ings than voided samples. Increased N/C ratio, irregular
nuclear border, cytoplasmic homogeneity, and presence
of several cell clusters had their highest incidence in the
LGUC. Necrosis was present only in carcinoma cases and
was rather infrequent.
Table IV summarizes the sensitivity, specificity, positive
predictive value and negative predictive value of the statis-
tically significant twelve features for the diagnosis of
LGUC. The increased N/C ratio, cytoplasmic homogeneity,
and irregular nuclear border had high sensitivities (67.5%,
65.1%, and 57.1%, respectively) and specificities (82.2%,
84.4%, and 91.1%, respectively) on ThinPrep specimens.
The positive predictive values (PPVs), which were all
higher than 90%, were much higher than the negative pre-
dictive values, which were all lower than 50%. Nuclear
eccentricity, nuclear molding, and anisonucleosis were also
good predictors, with sensitivity and specificity 61.9% and
82.2%, 41.3% and 93.3%, and 34.1% and 97.8%, respec-
tively. High cellularity, open chromatin, acute inflamma-
tion, irregularly bordered fragments, prominent nucleoli,
and peripheral palisading were not statistically significant
(P  0.01) either in washings or voided urine samples
(Table V).
Discussion
In urine cytology, high-grade urothelial carcinoma and car-
cinoma in situ usually do not represent a diagnostic chal-
lenge. The urine samples in such cases are characterized by
abundant cellularity, isolated and loose clusters of tumor
cells with pleomorphism and polymorphism, high N/C ratio,
enlarged and eccentric nucleus, hyperchromatic and coarse
chromatin, irregular nuclear membrane, and vacuolated cy-
toplasm.13 However, in LGUC, many of the above features
do not occur frequently. Histologically, LGUC are charac-
terized by an overall orderly appearance, but with easily
recognizable variation of architectural and/or cytologic fea-
tures. Cytologic atypia usually is definite but minimal, in-
cluding changes in nuclear size, shape, and chromatin pat-
tern. Therefore, the differentiation between low-grade
tumor and benign reactive or reparative change is very
difficult on cytologic specimens.4,5,14 Increased N/C, irreg-
ular nuclear membrane, and cytoplasmic homogeneity have
been proposed for diagnosing LGUC and, in combination,
Table I. Original Cytologic Diagnosis in Biopsy-confirmed Low-Grade
Urothelial Carcinomas and Benign Changes
LGUCa Benignb
TotalPositivec Negatived Positivec Negatived
Washinge 23 27 0 17 67
Voided 14 62 0 28 104
aTissue biopsy confirmed low-grade urothelial carcinoma case numbers.
bTissue biopsy confirmed benign lesion case numbers.
cPositive cases includes both positive and suspicious for urothelial carci-
noma.
dNegative cases include atypical cells present and negative for carcinoma.
eAll washing specimens including catheter-collected specimens.
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these three criteria had a 45% sensitivity and 98% specific-
ity in conventional (cytospin) bladder washings.5
Urine cytology is still one of the main approaches to
follow-up evaluation of patients with urothelial carcino-
mas.15,16 There are two major types of urinary cytologic
specimen: bladder washings (including catheterization spec-
imens) and voided urine specimens. Voided urines are easy
to obtain, and they represent the entire urinary tract. How-
ever, they usually have a low cellularity and carry a high
incidence of degeneration and contamination. In contrast,
bladder washings have a higher sensitivity, being more
cellular with better cell preservation and less contamination.
However, their collection is inconvenient and uncomfort-
able to the patient, and also carries an increased risk of
infection.15,17 A previous study claimed that ThinPrep could
achieve better cellular preservation, cleaner background and
high cellularity in voided urine samples compared to con-
ventional preparations.18
In this study, we found that increased N/C ratio, irregular
nuclear membrane, and cytoplasmic homogeneity were still
three key criteria in diagnosing LGUC in ThinPrep samples. In
combination, these three features had a sensitivity of 59% and
a specificity of 100%. We noted a slight difference between
our sensitivity in the second review and the original cytologic
diagnosis, which is not statistically significant (59% vs 46%).
This is probably due to the variation of different observers’
criteria on identifying these cytologic features.
Because urine cytology is more important as a screen-
ing test, high sensitivity is desirable. If we used either
two of the three key criteria, the diagnosis would have a
much higher sensitivity of 79% and a decreased speci-
ficity of 91%. To overcome this obstacle, other important
features such as eccentric nucleus, nuclear molding and
anisonucleosis were introduced. If we used two of the
three key features plus either one of these other important
features as the diagnostic standard, the diagnosis would
have a slightly decreased sensitivity of 77% and a mark-
edly increased specificity of 97%.
Fig. 1. Selected cytologic features in the diagnosing low-grade urothelial carcinoma in ThinPrep specimens. A: Aniso, anisonucleosis; Ecc Nucl, eccentric
nucleus; High N/C, high N/C ratio. B: Cyto homo, cytoplasmic homogeneity. C: Molding, nuclear molding. D: Elong Nucl, elongated nucleus. E: Hyper
chrom, hyperchromasia; Cyto collar, absence of cytoplasmic collar; Gran chrom, granular chromatin. F, Irreg Nucl Membrane, irregular nuclear membrane
(Papanicolaou stain, 1,000).










Washing 46.0 100 100 38.6
Voided 18.4 100 100 31.1
Combined 29.4 100 100 33.8
PPV, positive predictive value; NPV, negative predictive value.
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Although the three key cytologic features (increased N/C
ratio, irregular nuclear membrane, and cytoplasmic homo-
geneity) had similar occurrences in ThinPrep samples, some
cytologic alterations were noted in ThinPrep samples. In
carcinoma cases, nuclear molding and anisonucleosis had
much relative higher incidences in ThinPrep washing sam-
ples (62% and 58% vs 6% and 27%, respectively, in cyto-
spin samples). In noncarcinoma cases, only 6% had open or
vesicular nuclear chromatin compared with 22.0% in Thin-
Prep samples.5 Nevertheless, this study confirms that de-
spite such minor alterations ThinPrep produced well-pre-
served samples with even distribution of cells and
noticeable absence of most obscuring elements, such as
blood, inflammation, and proteinaceous background. The
diagnostic criteria derived from conventionally prepared
samples in diagnosing LGUC would still be applicable in
ThinPrep samples. In addition, as we showed in the study,
although the incidences of diagnostic cytologic features
were relatively low in the voided urine samples when com-
pared with washing samples, they shared similar patterns.
Therefore, the diagnostic criteria applicable to washings
would also apply to voided urine samples.
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